Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Theralase Technologies Inc (TLT.VN)

Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Theralase(R) Closes $1.3 M Non-Brokered Private Placement Newsfile - Tue Dec 23, 3:52PM CST

Toronto, Ontario--(Newsfile Corp. - December 23, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing Newsfile - Fri Dec 12, 4:08PM CST

Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study Newsfile - Mon Nov 24, 6:16AM CST

Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.155 (-3.13%)
Theralase(R) Investor Conference Call Reminder Newsfile - Mon Nov 17, 6:16AM CST

Theralase(R) Reminds Investors of Conference Call to Provide Update on Study II Interim Data Demonstrating 64.3% Complete ResponseToronto, Ontario--(Newsfile Corp. - November 17, 2025) - Theralase® Technologies...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Releases 3Q2025 Financial Statements Newsfile - Mon Nov 10, 6:14AM CST

Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug Newsfile - Mon Nov 3, 6:14AM CST

Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus Newsfile - Wed Sep 24, 6:08AM CDT

Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Extends Warrants Newsfile - Fri Aug 29, 3:44PM CDT

Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Releases 2Q2025 Financial Statements Newsfile - Tue Aug 26, 3:44PM CDT

Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)
Theralase(R) Closes Non-Brokered Private Placement Newsfile - Mon Jul 28, 6:02AM CDT

Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.155 (-3.13%)
TLTFF : 0.1140 (-3.55%)

Barchart Exclusives

Why This Top 100 Stock to Buy Is Getting Cheaper Even as It Soars Higher Barchart - 21 minutes ago
Virginia-based Indivior, a developer of opioid addiction treatments, continues to hold down a place in Barchart’s Top 100 Stocks to Buy. Up 192% in 2025, its P/E is declining despite the stock’s gains over the past year. Here’s why. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot